Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis

Steroids

Volumn 91, Issue , 2014, Pages 20-31

  Gomez Sanchez, Elise P ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

11 Hydroxysteroid dehydrogenase; Aldosterone; Cardiovascular disease; Cognition; Mineralocorticoid receptor

Indexed keywords

MINERALOCORTICOID RECEPTOR;

ANIMAL; BIOLOGICAL MODEL; BRAIN; CARDIOVASCULAR SYSTEM; COGNITION; HOMEOSTASIS; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN; CARDIOVASCULAR SYSTEM; COGNITION; HOMEOSTASIS; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, MINERALOCORTICOID;

EID: 84908667474     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2014.08.014     Document Type: Review

References (310)

1. M. Gekle, M. Bretschneider, S. Meinel, S. Ruhs, and C. Grossmann Rapid mineralocorticoid receptor trafficking Steroids 81 2014 103 108
2. S. Meinel, M. Gekle, and C. Grossmann Mineralocorticoid receptor signaling: crosstalk with membrane receptors and other modulators Steroids 2014
3. B.J. Harvey, R. Alzamora, A.K. Stubbs, M. Irnaten, V. McEneaney, and W. Thomas Rapid responses to aldosterone in the kidney and colon J Steroid Biochem Mol Biol 2007
4. R. Losel, A. Schultz, and M. Wehling A quick glance at rapid aldosterone action Mol Cell Endocrinol 217 2004 137 141
5. S. Quinn, B.J. Harvey, and W. Thomas Rapid aldosterone actions on epithelial sodium channel trafficking and cell proliferation Steroids 81 2014 43 48
6. F.L. Groeneweg, H. Karst, E.R. de Kloet, and M. Joels Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling Mol Cell Endocrinol 350 2012 299 309
7. A.W. Krug, L.H. Pojoga, G.H. Williams, and G.K. Adler Cell membrane-associated mineralocorticoid receptors? New evidence Hypertension 57 2011 1019 1025
8. E.P. Gomez-Sanchez, and C.E. Gomez-Sanchez Central regulation of blood pressure by the mineralocorticoid receptor Mol Cell Endocrinol 350 2012 289 298
9. E. Gomez-Sanchez, and C.E. Gomez-Sanchez The multifaceted mineralocorticoid receptor. Comprehensive Physiology 4 2014 965 994
10. C. Grossmann, S. Ruhs, L. Langenbruch, S. Mildenberger, N. Stratz, and K. Schumann Nuclear shuttling precedes dimerization in mineralocorticoid receptor signaling Chem Biol 19 2012 742 751
11. L. Martinerie, M. Munier, D. Le Menuet, G. Meduri, S. Viengchareun, and M. Lombes The mineralocorticoid signaling pathway throughout development: expression, regulation and pathophysiological implications Biochimie 95 2013 148 157
12. S. Viengchareun, D. Le Menuet, L. Martinerie, M. Munier, L. Pascual-Le Tallec, and M. Lombes The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology Nucl Recept Signal 5 2007 e012
13. L. Pascual-Le Tallec, and M. Lombes The mineralocorticoid receptor: a journey exploring its diversity and specificity of action Mol Endocrinol 19 2005 2211 2221
14. K. Kuroda, R. Venkatakrishnan, M.S. Salker, E.S. Lucas, F. Shaheen, and M. Kuroda Induction of 11beta-HSD 1 and activation of distinct mineralocorticoid receptor- and glucocorticoid receptor-dependent gene networks in decidualizing human endometrial stromal cells Mol Endocrinol 27 2013 192 202
15. D. Ackermann, N. Gresko, M. Carrel, D. Loffing-Cueni, D. Habermehl, and C. Gomez-Sanchez In vivo nuclear translocation of mineralocorticoid and glucocorticoid receptors in rat kidney: differential effect of corticosteroids along the distal tubule Am J Physiol Renal Physiol 299 2010 F1473 F1485
16. J. Yang, and M.J. Young The mineralocorticoid receptor and its coregulators J Mol Endocrinol 43 2009 53 64
17. K. Yokota, H. Shibata, I. Kurihara, S. Kobayashi, N. Suda, and A. Murai-Takeda Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9 J Biol Chem 282 2007 1998 2010
18. N. Farman, and M.E. Rafestin-Oblin Multiple aspects of mineralocorticoid selectivity Am J Physiol Renal Physiol 280 2001 F181 F192
19. N.A. Datson, J. van der Perk, E.R. de Kloet, and E. Vreugdenhil Identification of corticosteroid-responsive genes in rat hippocampus using serial analysis of gene expression Eur J Neurosci 14 2001 675 689
20. E.R. De Kloet, S.A. Van Acker, R.M. Sibug, M.S. Oitzl, O.C. Meijer, and K. Rahmouni Brain mineralocorticoid receptors and centrally regulated functions Kidney Int 57 2000 1329 1336
21. J.E. Olijslagers, E.R. de Kloet, Y. Elgersma, G.M. van Woerden, M. Joels, and H. Karst Rapid changes in hippocampal CA1 pyramidal cell function via pre- as well as postsynaptic membrane mineralocorticoid receptors Eur J Neurosci 27 2008 2542 2550
22. M. Quinkler, S. Johanssen, C. Bumke-Vogt, W. Oelkers, V. Bahr, and S. Diederich Enzyme-mediated protection of the mineralocorticoid receptor against progesterone in the human kidney Mol Cell Endocrinol 171 2001 21 24
23. M.J. Gray, K.S. Strausfeld, M. Watanabe, E.A. Sims, and S. Solomon Aldosterone secretory rates in the normal menstrual cycle J Clin Endocrinol Metab 28 1968 1269 1275
24. B.A. Clark, D. Elahi, and F.H. Epstein The influence of gender, age, and the menstrual cycle on plasma atrial natriuretic peptide J Clin Endocrinol Metab 70 1990 349 352
25. E. Boschitsch, S. Mayerhofer, and D. Magometschnigg Hypertension in women: the role of progesterone and aldosterone Climacteric 13 2010 307 313
26. A.H. Ahmed, R.D. Gordon, P.J. Taylor, G. Ward, E. Pimenta, and M. Stowasser Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men? J Clin Endocrinol Metab 96 2011 E340 E346
27. E.P. Gomez-Sanchez, M.T. Gomez-Sanchez, A.F. de Rodriguez, D.G. Romero, M.P. Warden, and M.W. Plonczynski Immunohistochemical Demonstration of the Mineralocorticoid Receptor, 11{beta}-Hydroxysteroid Dehydrogenase-1 and -2, and Hexose-6-phosphate Dehydrogenase in Rat Ovary J Histochem Cytochem 57 2009 633 641
28. C.E. Gomez-Sanchez, A.F. de Rodriguez, D.G. Romero, J. Estess, M.P. Warden, and M.T. Gomez-Sanchez Development of a panel of monoclonal antibodies against the mineralocorticoid receptor Endocrinology 147 2006 1343 1348
29. P.M. Driver, S. Rauz, E.A. Walker, M. Hewison, M.D. Kilby, and P.M. Stewart Characterization of human trophoblast as a mineralocorticoid target tissue Mol Hum Reprod 9 2003 793 798
30. J.W. Funder Why are mineralocorticoid receptors so nonselective? Curr Hypertens Rep 9 2007 112 116
31. R. Gros, Q. Ding, B. Liu, J. Chorazyczewski, and R.D. Feldman Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation Am J Physiol Cell Physiol 304 2013 C532 C540
32. L.H. Pojoga, P. Coutinho, A. Rivera, T.M. Yao, E.R. Maldonado, and R. Youte Activation of the mineralocorticoid receptor increases striatin levels Am J Hypertens 25 2012 243 249
33. W.W. Batenburg, P.M. Jansen, and A.J. van den Bogaerdt AH JD. Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase Cardiovasc Res 94 2012 136 143
34. R. Gros, Q. Ding, L.A. Sklar, E.E. Prossnitz, J.B. Arterburn, and J. Chorazyczewski GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone Hypertension 57 2011 442 451
35. R. Gros, Q. Ding, M. Davis, R. Shaikh, B. Liu, and J. Chorazyczewski Delineating the receptor mechanisms underlying the rapid vascular contractile effects of aldosterone and estradiol Can J Physiol Pharmacol 89 2011 655 663
36. M. Steiger, and T. Reichstein Desoxy-corticosterone (21-oxy-progesterone). Aus d-3-oxo-etiocholensäure Helv Chim Acta 20 1937 1164
37. W.W. Swingle, R. Maxwell, M. Ben, C. Baker, S.J. Lebrie, and M. Eisler A comparative study of aldosterone and other adrenal steroids in adrenalectomized dogs Endocrinology 65 1954 813 821
38. D.J. Ingle The relationship of the adrenal cortex to homeostasis J Michigan State Med Soc 49 1950 943
39. D.J. Ingle, M.C. Prestrud, and C.H. Li A further study of the essentiality of the adrenal cortex in mediating the metabolic effects of adrenocorticotrophic hormone Endocrinology 43 1948 202 207
40. S.A. Simpson, and J.F. Tait Recent progress in methods of isolation, chemistry, and physiology of aldosterone Recent Prog Horm Res 11 1955 183 219
41. E.C. Kendall Hormones of the adrenal cortex in clinical medicine Edinburgh Med J 59 1952 1 12
42. I.E. Bush Chemical and biological factors in the activity of adrenocortical steroids Pharmacol Rev 14 1962 317 445
43. S.A. Tait, and J.F. Tait The correspondence of S.A.S. Simpson and J.F. Tait with T. Reichstein during their collaborative work on the isolation and elucidation of the structure of electrocortin (later aldosterone) Steroids 63 1998 440 453
44. D. Kuhlman, C. Ragan, J.W. Ferrebee, D.W. Atchley, and R.F. Loeb Toxic effects of deoxycorticosterone esters in dogs Science 90 1939 496 497
45. S. Rodbard, and S.C. Freed The effect of desoxycorticosterone acetate on the blood pressure of the dog Endocrinology 30 1942 365 368
46. H.M. Grundy, S.A. Simpson, and J.F. Tait Isolation of a highly active mineralocorticoid from beef adrenal extract Nature 169 1952 795 796
47. G. Sala, and J.A. Luetscher Jr. The effect of sodium-retaining corticoid, electrocortin, desoxycorticosterone, and cortisone on renal function and excretion of sodium and water in adrenalectomized rats Endocrinology 55 1954 516 518
48. D. Pearce, and T.R. Kleyman Salt, sodium channels, and SGK1 J Clin Invest 117 2007 592 595
49. R. Soundararajan, M. Lu, and D. Pearce Organization of the ENaC-regulatory machinery Crit Rev Biochem Mol biol 47 2012 349 359
50. J.W. Conn Primary aldosteronism, a new clinical syndrome J Lab Clin Med 45 1955 3 7
51. J.B. Ferriss, D.G. Beevers, J.J. Brown, D.L. Davies, R. Fraser, and A.F. Lever Clinical, biochemical and pathological features of low-renin ("primary") hyperaldosteronism Am Heart J 95 1978 375 388
52. A. Tanabe, M. Naruse, K. Naruse, M. Hase, T. Yoshimoto, and M. Tanaka Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension Hypertension Res 20 1997 85 90
53. G.P. Rossi, A. Sacchetto, E. Pavan, P. Palatini, G.R. Graniero, and C. Canali Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma Circulation 95 1997 1471 1478
54. U.A. Hawkins, E.P. Gomez-Sanchez, C.M. Gomez-Sanchez, and C.E. Gomez-Sanchez The ubiquitous mineralocorticoid receptor: clinical implications Curr Hypertens Rep 14 2012 573 580
55. D.A. Calhoun Hyperaldosteronism as a common cause of resistant hypertension Annu Rev Med 64 2013 233 247
56. N. Sonino, E. Tomba, M.L. Genesia, C. Bertello, P. Mulatero, and F. Veglio Psychological assessment of primary aldosteronism: a controlled study J Clin Endocrinol Metab 96 2011 E878 E883
57. N. Sonino, F. Fallo, and G.A. Fava Psychological aspects of primary aldosteronism Psychother Psychosom 75 2006 327 330
58. H.E. Kunzel, K. Apostolopoulou, A. Pallauf, S. Gerum, K. Merkle, and S. Schulz Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone J Psychiatr Res 46 2012 1650 1654
59. H.E. Kunzel Psychopathological symptoms in patients with primary hyperaldosteronism-possible pathways Horm Metab Res 44 2012 202 207
60. W. Raab, R.J. Humphreys, and E. Lepeschkin Potentiation of pressor effects of nor-epinephrine and epinephrine in man by desoxycorticosterone acetate J Clin Invest 29 1950 1397 1404
61. V.R. Mattox, H.L. Mason, A. Albert, and C.F. Code Properties of a sodium-retaining principle from beef adrenal extract J Am Chem Soc 75 1953 4869 4870
62. J.C. Vanatta, and K.E. Cottle Effect of desoxycorticosterone acetate on the peripheral vascular reactivity of dogs Am J Physiol 151 1955 119 122
63. A.W. Jones, and R.G. Hart Altered ion transport in aortic smooth muscle during deoxycorticosterone acetate hypertension in rats Circ Res 37 1975 333 341
64. K.H. Berecek, and D.F. Bohr Structural and functional changes in vascular resistance and reactivity in the deoxycorticosterne acetate (DOCA)-hypertensive pig Circ Res 40 5 1977 1146 1152
65. K.H. Berecek, M. Stocker, and F. Gross Changes in renal vascular reactivity at variuos stages of deoxycorticosterone hypertension in rats Circ Res 46 1980 H619-H203
66. E.T. Garwitz, and A.W. Jones Altered arterial ion transport and its reversal in aldosterone hypertensive rat Am J Physiol 243 1982 H927 H933
67. J.J. DuPont, M.A. Hill, S.B. Bender, F. Jaisser, and I.Z. Jaffe Aldosterone and vascular mineralocorticoid receptors: regulators of ion channels beyond the kidney Hypertension 63 2014 632 637
68. S. Messaoudi, F. Azibani, C. Delcayre, and F. Jaisser Aldosterone, mineralocorticoid receptor, and heart failure Mol Cell Endocrinol 350 2012 266 272
69. A. McCurley, and I.Z. Jaffe Mineralocorticoid receptors in vascular function and disease Mol Cell Endocrinol 350 2012 256 265
70. M. Briet, and E.L. Schiffrin Vascular actions of aldosterone J Vasc Res 50 2013 89 99
71. E.L. Schiffrin The many targets of aldosterone Hypertension 43 2004 938 940
72. E.L. Schiffrin Effects of aldosterone on the vasculature Hypertension 47 2006 312 318
73. C.S. Rigsby, A. Ergul, V. Portik Dobos, D.M. Pollock, and A.M. Dorrance Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension Am J Hypertens 24 2011 708 715
74. A.M. Dorrance, H.L. Osborn, R. Grekin, and R.C. Webb Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats Am J Physiol Regul Integr Comp Physiol 281 2001 R944 R950
75. M.J. Brody, G.D. Fink, J. Buggy, J.R. Haywood, F.J. Gordon, and A.K. Johnson The role of the anteroventral third ventrical (AV3V) region in experimental hypertension Circ Res 43 1978 2 13
76. M.J. Brody, K.J. Varner, E.C. Vasquez, and S.J. Lewis Central nervous system and the pathogenesis of hypertension. Sites and mechanisms Hypertension 18 1991 III7 III12
77. S.L. Bealer Anteroventral third ventricle periventricular tissue contributes to cardiac baroreflex responses Clin Exp Pharmacol Physiol 27 2000 460 464
78. T. Kubo, and M. Hashimoto Effects of intraventricular and intraspinal 6-hyroxydopamine and blood pressure of DOCA-saline hypertensive rats Arch Int Pharmacodyn 238 1979 50 59
79. A. Takeshita, A.L. Mark, and M.J. Brody Prevention of salt-induced hypertension in Dahl strain by 6-hyrdoxydopamine Am J Physiol 236 1979 H48 H52
80. S. Pyner Neurochemistry of the paraventricular nucleus of the hypothalamus: implications for cardiovascular regulation J Chem Neuroanat 38 2009 197 208
81. A.V. Ferguson, K.J. Latchford, and W.K. Samson The paraventricular nucleus of the hypothalamus - a potential target for integrative treatment of autonomic dysfunction Expert Opin Ther Targets 12 2008 717 727
82. J. Chen, C.E. Gomez-Sanchez, A. Penman, P.J. May, and E.P. Gomez-Sanchez Expression of mineralocorticoid and glucocorticoid receptors in pre-autonomic neurons of the rat paraventricular nucleus Am J Physiol Regul Integr Comp Physiol 2013
83. E.P. Gomez-Sanchez Intracerebroventricular infusion of aldosterone induces hypertension in rats Endocrinology 118 1986 819 823
84. M.J. Young, and J.W. Funder Mineralocorticoids, salt, hypertension: effects on the heart Steroids 61 1996 233 235
85. P.C. Janiak, S.J. Lewis, and M.J. Brody Role of central mineralocorticoid binding sites in development of hypertension Am J Physiol 259 1990 R1025 R1034
86. K. Rahmouni, M. Barthelmebs, M. Grima, J.L. Imbs, and W. De Jong Involvement of brain mineralocorticoid receptor in salt-enhanced hypertension in spontaneously hypertensive rats Hypertension 38 2001 902 906
87. B.S. Huang, R.A. White, A.Y. Jeng, and F.H. Leenen Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats Am J Physiol Regul Integr Comp Physiol 296 2009 R994 R1000
88. E.P. Gomez-Sanchez, and C.E. Gomez-Sanchez The effect of the central infusion of benzamil on Dahl S rat hypertension Am J Physiol 269 1995 H1044 H1047
89. E.P. Gomez-Sanchez, and C.E. Gomez-Sanchez Effect of central amiloride infusion on mineralocorticoid hypertension Am J Physiol 267 1994 E754 E758
90. R.F. Keep, X. Si, P. Shakui, S.R. Ennis, and A.L. Betz Effect of amiloride analogs on DOCA-salt-induced hypertension in rats Am J Physiol 276 1999 H2215 H2220
91. J.M. Abrams, W.C. Engeland, and J.W. Osborn Effect of intracerebroventricular benzamil on cardiovascular and central autonomic responses to DOCA-salt treatment Am J Physiol Regul Integr Comp Physiol 299 2010 R1500 R1510
92. B.S. Huang, and F.H. Leenen Blockade of brain mineralocorticoid receptors or Na+ channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI Am J Physiol Heart Circ Physiol 288 2005 H2491 H2497
93. B.S. Huang, and F.H. Leenen Brain amiloride-sensitive Phe-Met-Arg-Phe-NH(2)-gated Na(+) channels and Na(+)-induced sympathoexcitation and hypertension Hypertension 39 2002 557 561
94. K. Rahmouni, M. Barthelmebs, M. Grima, J.L. Imbs, and J. De Wybren Brain mineralocorticoid receptor control of blood pressure and kidney function in normotensive rats Hypertension 33 1999 1201 1206
95. B.S. Huang, H. Wang, and F.H. Leenen Enhanced sympathoexcitatory and pressor responses to central Na+ in Dahl salt-sensitive vs. -resistant rats Am J Physiol Heart Circ Physiol 281 2001 H1881 H1889
96. B. Xue, T.G. Beltz, Y. Yu, F. Guo, C.E. Gomez-Sanchez, and M. Hay Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension Am J Physiol Heart Circ Physiol 300 2011 H555 H564
97. L.J. Kaufman, and R.R. Vollmer Low sodium diet augments plasma and tissue catecholamine levels in pithed rats Clin Exp Hypertens A 6 1984 1543 1558
98. M.V. Vitiello, P.N. Prinz, and J.B. Halter Sodium-restricted diet increases nighttime plasma norepinephrine and impairs sleep patterns in man J Clin Endocrinol Metab 56 1983 553 556
99. A.K. Johnson, and R.L. Thunhorst The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration Front Neuroendocrinol 18 1997 292 353
100. J.C. Geerling, and A.D. Loewy Central regulation of sodium appetite Exp Physiol 93 2008 177 209
101. B. Lu, X.J. Yang, K. Chen, D.J. Yang, and J.Q. Yan Dietary sodium deprivation evokes activation of brain regional neurons and down-regulation of angiotensin II type 1 receptor and angiotensin-convertion enzyme mRNA expression Neuroscience 164 2009 1303 1311
102. A.J. Relman, and W.B. Schwartz The effect of DOCA on electrolyte balance in normal man and its relation to sodium intake Yale J Biol Med 24 1952 540 556
103. C.E. Hall, and O. Hall Interaction between deoxycorticosterone treatment, fluid intake, sodium consumption, blood pressure, and organ changes in rats during drinking water, saline, or sucrose solution J Physiol Pharmacol 47 1969 81 86
104. R.R. Sakai, S. Nicolaidis, and A.N. Epstein Salt appetite is suppressed by interference with angiotensin II and aldosterone Am J Physiol 251 1986 R762 R768
105. R.R. Sakai, B.S. McEwen, S.J. Fluharty, and L.Y. Ma The amygdala: site of genomic and nongenomic arousal of aldosterone-induced sodium intake Kidney Int 57 2000 1337 1345
106. J.C. Geerling, W.C. Engeland, M. Kawata, and A.D. Loewy Aldosterone target neurons in the nucleus tractus solitarius drive sodium appetite J Neurosci 26 2006 411 417
107. J.W. Shin, J.C. Geerling, and A.D. Loewy Inputs to the ventrolateral bed nucleus of the stria terminalis J Comp Neurol 511 2008 628 657
108. E.P. Gomez-Sanchez Dose-response studies of intracerebroventricular infusion of aldosterone in sensitized and nonsensitized rats J Hypertension 6 1988 437 442
109. S. Formenti, M. Bassi, N.B. Nakamura, G.H. Schoorlemmer, J.V. Menani, and E. Colombari Hindbrain mineralocorticoid mechanisms on sodium appetite Am J Physiol Regul Integr Comp Physiol 304 2013 R252 R259
110. J.C. Geerling, and A.D. Loewy Aldosterone-sensitive neurons in the nucleus of the solitary tract: bidirectional connections with the central nucleus of the amygdala J Comp Neurol 497 2006 646 657
111. W. Martus, D. Kim, J.L. Garvin, and W.H. Beierwaltes Commercial rodent diets contain more sodium than rats need Am J Physiol Renal Physiol 288 2005 F428 F431
112. E.P. Gomez-Sanchez, M.Y. Zhou, and C.E. Gomez-Sanchez Mineralocorticoids, salt and high blood pressure: causes Steroids 61 1996 184 188
113. M.J. Young, and A.J. Rickard Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis Mol Cell Endocrinol 350 2012 248 255
114. B. Pitt Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies Mol Cell Endocrinol 217 2004 53 58
115. B. Pitt, F. Zannad, R. Cody, A.P.A. Castaigne, J. Palensky, and J. Wittes The effect of spironolactone on mobidity and mortality in patients with severe heart failure. Randomized Aldactone evaluation study investigators New Engl J Med 341 1999 709 717
116. M.A. Pfeffer New treasures from old? EPHESUS. Eplerenome post-AHI heart failure efficacy and survival study Cardiovasc Drugs Ther 15 2001 11 13
117. P. Rossignol, J. Menard, R. Fay, F. Gustafsson, B. Pitt, and F. Zannad Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy J Am Coll Cardiol 58 2011 1958 1966
118. F. Zannad, J.J. McMurray, H. Krum, D.J. van Veldhuisen, K. Swedberg, and H. Shi Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
119. N.C. Bene, P. Alcaide, H.H. Wortis, and I.Z. Jaffe Mineralocorticoid receptors in immune cells: Emerging role in cardiovascular disease Steroids 2014
120. I.Z. Jaffe, and F. Jaisser Endothelial cell mineralocorticoid receptors: turning cardiovascular risk factors into cardiovascular dysfunction Hypertension 63 2014 915 917
121. J.B. Koenig, and I.Z. Jaffe Direct role for smooth muscle cell mineralocorticoid receptors in vascular remodeling: novel mechanisms and clinical implications Curr Hypertens Rep 16 2014 427
122. D. Pruthi, A. McCurley, M. Aronovitz, C. Galayda, S.A. Karumanchi, and I.Z. Jaffe Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors Arterioscler Thromb Vasc Biol 34 2014 355 364
123. G.H. Williams Cardiovascular benefits of aldosterone receptor antagonists Climacteric 6 Suppl 3 2003 29 35
124. E.R. Blasi, R. Rocha, A.E. Rudolph, E.A. Blomme, M.L. Polly, and E.G. McMahon Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats Kidney Int 63 2003 1791 1800
125. R. Rocha, A.E. Rudolph, G.E. Frierdich, D.A. Nachowiak, B.K. Kekec, and E.A. Blomme Aldosterone induces a vascular inflammatory phenotype in the rat heart Am J Physiol Heart Circ Physiol 283 2002 H1802 H1810
126. R Rocha, and J.W. Funder The pathophysiology of aldosterone in the cardiovascular system Ann N Y Acad Sci 970 2002 89 100
127. J.M. Luther, J.V. Gainer, L.J. Murphey, C. Yu, D.E. Vaughan, and J.D. Morrow Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism Hypertension 48 2006 1050 1057
128. N. Queisser, and N. Schupp Aldosterone, oxidative stress, and NF-kappaB activation in hypertension-related cardiovascular and renal diseases Free Rad Biol Med 53 2012 314 327
129. N. Queisser, G. Fazeli, and N. Schupp Superoxide anion and hydrogen peroxide-induced signaling and damage in angiotensin II and aldosterone action Biol Chem 391 2010 1265 1279
130. M.K. Rude, T.A. Duhaney, G.M. Kuster, S. Judge, J. Heo, and W.S. Colucci Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes Hypertension 46 2005 555 561
131. C.I. Caldiz, R.G. Diaz, M.B. Nolly, G.E. Chiappe de Cingolani, I.L. Ennis, and H.E. Cingolani Mineralocorticoid receptor activation is crucial in the signalling pathway leading to the Anrep effect J Physiol 589 2011 6051 6061
132. N. Maggio, and M. Segal Cellular basis of a rapid effect of mineralocorticosteroid receptors activation on LTP in ventral hippocampal slices Hippocampus 22 2012 267 275
133. M.J. Glass, J. Chan, K.A. Frys, M. Oselkin, M.J. Tarsitano, and C. Iadecola Changes in the subcellular distribution of NADPH oxidase subunit p47phox in dendrites of rat dorsomedial nucleus tractus solitarius neurons in response to chronic administration of hypertensive agents Exp Neurol 205 2007 383 395
134. F. Kawakami-Mori, T. Shimosawa, S. Mu, H. Wang, S. Ogura, and Y. Yatomi NADPH oxidase-mediated Rac1 GTP activity is necessary for nongenomic actions of the mineralocorticoid receptor in the CA1 region of the rat hippocampus Am J Physiol Endocrinol Metab 302 2012 E425 E432
135. Y.M. Kang, Y. Ma, J.P. Zheng, C. Elks, S. Sriramula, and Z.M. Yang Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension Cardiovasc Res 82 2009 503 512
136. A.-M. Moura, and M. Worcel Direct action of aldosterone on transmembrane 22Na efflux from arterial smooth muscle: rapid and delayed effects Hypertension 6 1984 425 430
137. A. Fiebeler, and F.C. Luft The mineralocorticoid receptor and oxidative stress Heart Fail Rev 10 2005 47 52
138. A.M. Marney, and N.J. Brown Aldosterone and end-organ damage Clin Sci (Lond) 113 2007 267 278
139. C. Grossmann, and M. Gekle New aspects of rapid aldosterone signaling Mol Cell Endocrinol 308 2009 53 62
140. G.E. Callera, A. Yogi, A.M. Briones, A.C. Montezano, Y. He, and R.C. Tostes Vascular proinflammatory responses by aldosterone are mediated via c-Src trafficking to cholesterol-rich microdomains: role of PDGFR Cardiovasc Res 91 2011 720 731
141. A.T. Whaley-Connell, J. Habibi, R. Nistala, V.G. DeMarco, L. Pulakat, and M.R. Hayden Mineralocorticoid receptor-dependent proximal tubule injury is mediated by a redox-sensitive mTOR/S6K1 pathway Am J Nephrol 35 2012 90 100
142. A. Wendler, C. Albrecht, and M. Wehling Nongenomic actions of aldosterone and progesterone revisited Steroids 77 2012 1002 1006
143. X. Zhu, R.D. Manning Jr., D. Lu, C.E. Gomez-Sanchez, Y. Fu, and L.A. Juncos Aldosterone stimulates superoxide production in macula densa cells Am J Physiol Renal Physiol 301 2011 F529 F535
144. Y.M. Kang, Z.H. Zhang, R.F. Johnson, Y. Yu, T. Beltz, and A.K. Johnson Novel effect of mineralocorticoid receptor antagonism to reduce proinflammatory cytokines and hypothalamic activation in rats with ischemia-induced heart failure Circ Res 99 2006 758 766
145. S. Schiavone, V. Jaquet, S. Sorce, M. Dubois-Dauphin, M. Hultqvist, and L. Backdahl NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology Transl Psychiatry 2 2012 e111
146. J.S. Seo, J.Y. Park, J. Choi, T.K. Kim, J.H. Shin, and J.K. Lee NADPH oxidase mediates depressive behavior induced by chronic stress in mice J Neurosci 32 2012 9690 9699
147. Z.H. Zhang, Y. Yu, S.G. Wei, and R.B. Felder Centrally administered lipopolysaccharide elicits sympathetic excitation via NAD(P)H oxidase-dependent mitogen-activated protein kinase signaling J Hypertens 28 2010 806 816
148. A. Gabor, and F.H. Leenen Central neuromodulatory pathways regulating sympathetic activity in hypertension J Appl Physiol 113 2012 1294 1303
149. R.B. Felder Mineralocorticoid receptors, inflammation and sympathetic drive in a rat model of systolic heart failure Exp Physiol 95 2010 19 25
150. E.R. de Kloet, H. Karst, and M. Joels Corticosteroid hormones in the central stress response: quick-and-slow Front Neuroendocrinol 29 2008 268 272
151. M. Nagase, and T. Fujita Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease Nat Rev Nephrol 9 2013 86 98
152. J. Francis, T. Beltz, A.K. Johnson, and R.B. Felder Mineralocorticoids act centrally to regulate blood-borne tumor necrosis factor-alpha in normal rats Am J Physiol Regul Integr Comp Physiol 285 2003 R1402 R1409
153. Z.H. Zhang, J. Francis, R.M. Weiss, and R.B. Felder The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure Am J Physiol Heart Circ Physiol 283 2002 H423 H433
154. Y. Yu, Z.H. Zhang, S.G. Wei, J. Serrats, R.M. Weiss, and R.B. Felder Brain perivascular macrophages and the sympathetic response to inflammation in rats after myocardial infarction Hypertension 55 2010 652 659
155. E. Szczepanska-Sadowska, A. Cudnoch-Jedrzejewska, M. Ufnal, and T. Zera Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases J Physiol Pharmacol 61 2010 509 521
156. Y.M. Kang, Z.H. Zhang, B. Xue, R.M. Weiss, and R.B. Felder Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure Am J Physiol Heart Circ Physiol 295 2008 H227 H236
157. V.L. Brooks, and J.W. Osborn Hormonal-sympathetic interactions in long-term regulation of arterial pressure: an hypothesis Am J Physiol 268 1995 R1343 R1358
158. D.V. Menon, D. Arbique, Z. Wang, B. Adams-Huet, R.J. Auchus, and W. Vongpatanasin Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients J Clin Endocrinol Metab 94 2009 1361 1366
159. P. Raheja, A. Price, Z. Wang, D. Arbique, B. Adams-Huet, and R.J. Auchus Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients Hypertension 2012
160. G.P. Rossi, and T.M. Seccia Changes in aldosterone and obesity-related cardiometabolic risk factors with a 1-year weight loss intervention in normotensive overweight and obese young adults Hypertens Res 2013
161. A. Whaley-Connell, M.S. Johnson, and J.R. Sowers Aldosterone: role in the cardiometabolic syndrome and resistant hypertension Prog Cardiovasc Dis 52 2010 401 409
162. G. Lastra-Gonzalez, C. Manrique-Acevedo, and J.R. Sowers The role of aldosterone in cardiovascular disease in people with diabetes and hypertension: an update Curr Diab Rep 8 2008 203 207
163. A.P. Harris, M.C. Holmes, E.R. de Kloet, K.E. Chapman, and J.R. Seckl Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour Psychoneuroendocrinology 38 2013 648 658
164. M. Joels, R.A. Sarabdjitsingh, and H. Karst Unraveling the time domains of corticosteroid hormone influences on brain activity: rapid, slow, and chronic modes Pharmacol Rev 64 2012 901 938
165. D.L. Champagne, R.C. Bagot, F. van Hasselt, G. Ramakers, M.J. Meaney, and E.R. de Kloet Maternal care and hippocampal plasticity: evidence for experience-dependent structural plasticity, altered synaptic functioning, and differential responsiveness to glucocorticoids and stress J Neurosci 28 2008 6037 6045
166. N. Maggio, and M. Segal Striking variations in corticosteroid modulation of long-term potentiation along the septotemporal axis of the hippocampus J Neurosci 27 2007 5757 5765
167. C. Pavlides, and B.S. McEwen Effects of mineralocorticoid and glucocorticoid receptors on long-term potentiation in the CA3 hippocampal field Brain Res 851 1999 204 214
168. A.M. Stranahan, T.V. Arumugam, K. Lee, and M.P. Mattson Mineralocorticoid receptor activation restores medial perforant path LTP in diabetic rats Synapse 64 2010 528 532
169. J. Chen, C.E. Gomez-Sanchez, A. Penman, P.J. May, and E. Gomez-Sanchez Expression of mineralocorticoid and glucocorticoid receptors in preautonomic neurons of the rat paraventricular nucleus Am J Physiol Regul Integr Comp Physiol 306 2014 R328 R340
170. E.R. de Kloet, M.S. Oitzl, and M. Joels Stress and cognition: are corticosteroids good or bad guys? Trends Neurosci 22 1999 422 426
171. R.A. Sarabdjitsingh, M. Joels, and E.R. de Kloet Glucocorticoid pulsatility and rapid corticosteroid actions in the central stress response Physiol Behav 106 2012 73 80
172. L. Schwabe, M. Tegenthoff, O. Hoffken, and O.T. Wolf Mineralocorticoid receptor blockade prevents stress-induced modulation of multiple memory systems in the human brain Biol Psychiatry 74 2013 801 808
173. V. Brinks, S. Berger, P. Gass, E.R. de Kloet, and M.S. Oitzl Mineralocorticoid receptors in control of emotional arousal and fear memory Horm Behav 56 2009 232 238
174. D. Ferguson, and R. Sapolsky Overexpression of mineralocorticoid and transdominant glucocorticoid receptor blocks the impairing effects of glucocorticoids on memory Hippocampus 18 2008 1103 1111
175. Z.G. Hodgson, S.L. Meddle, M.L. Roberts, K.L. Buchanan, M.R. Evans, and R. Metzdorf Spatial ability is impaired and hippocampal mineralocorticoid receptor mRNA expression reduced in zebra finches (Taeniopygia guttata) selected for acute high corticosterone response to stress Proc Biol Sci 274 2007 239 245
176. S. Berger, D.P. Wolfer, O. Selbach, H. Alter, G. Erdmann, and H.M. Reichardt Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity Proc Natl Acad Sci USA 103 2006 195 200
177. M.J. Schaaf, E.R. De Kloet, and E. Vreugdenhil Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation Stress 3 2000 201 208
178. K.G. Alberti, and G.W. Sharp Four classes of steroid identified by their interaction with mineralocorticoid receptors in the toad bladder Biochem J 115 1969 45P
179. J.W. Funder, D. Feldman, and I. Edelman Specific Aldosterone binding in rat kidney and parotid J Steroid Biochem 3 1972 209 218
180. G. Rousseau, J.D. Baxter, J.W. Funder, I.S. Edelman, and G.M. Tomkins Glucocorticoid and mineralocorticoid receptors for aldosterone J Steroid Biochem 3 1972 219 227
181. G.P. Vinson The mislabelling of deoxycorticosterone: making sense of corticosteroid structure and function J Endocrinol 211 2011 3 16
182. J.L. Gerlach, and B.S. McEwen Rat brain binds adrenal steroid hormone: radioautography of hippocampus with corticosterone Science 175 1972 1133 1136
183. Stumpf WE, Sar M. Glucocorticosteroids and mineralocorticosteroid hormone target sites in the brain. Autoradiographic studies with corticosterone, aldosterone, deoxycorticosterone: in interaction within the brain-pituitary-adrenocortical system. Within the Brain-Pituitary-Adrenocortical System: Academic Press; 1979. p. 137-47.
184. M.K. Birmingham, M. Sar, and W.E. Stumpf Localization of aldosterone and corticosterone in the central nervous system, assessed by quantitative autoradiography Neurochem Res 9 1984 333 350
185. E.R. De Kloet Brain corticosteroid receptor balance and homeostatic control Front Neuroendocrinol 12 1991 95 164
186. D. Marver, J. Stewart, J.W. Funder, D. Feldman, and I.S. Edelman Renal aldosterone receptors: studies with (3H)aldosterone and the anti-mineralocorticoid (3H)spirolactone (SC-26304) Proc Natl Acad Sci USA 71 1974 1431 1435
187. B.G. Yongue, and E.J. Roy Endogenous aldosterone and corticosterone in brain cell nuclei of adrenal-intact rats: regional distribution and effects of physiological variations in serum steroids Brain Res 436 1987 49 61
188. H. Selye The general adaptation syndrome and the diseases of adaptation J Clin Endocrinol Metab 6 1946 117 230
189. E.R. de Kloet, I.E. de Jong, and M.S. Oitzl Neuropharmacology of glucocorticoids: focus on emotion, cognition and cocaine Eur J Pharmacol 585 2008 473 482
190. B.S. McEwen, J.M. Weiss, and L.S. Schwartz Selective retention of corticosterone by limbic structures in rat brain Nature 220 1968 911 912
191. J.M.H. Reul, and E.R. De Kloet Two receptor systems for coticosterone in rat brain: microdistribution and differential occupation Endocrinology 117 1985 2505 2511
192. H. Coirini, E.T. Marusic, A.F. De Nicola, T.C. Rianbow, and B.S. McEwen Identification of mineralocorticoid binding sites in rat brain by competition studies and density gradient centrifugation Neuroendocrinology 37 1983 354 360
193. Z.S. Krozowski, and J.W. Funder Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity Proc Natl Acad Sci USA 80 1983 6056 6060
194. J.L. Arriza, R.B. Simerly, L.W. Swanson, and R.M. Evans The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response Neuron 1 1988 887 900
195. S. Ulick, L.S. Levine, and P. Gunczler A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol J Clin Endocrinol Metab 49 1979 757 764
196. C.H.L. Shackleton, J.R.E. Arteaga, J.M. Lopez, and J.S.D. Winter Congenital 11β-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families Clin Endocrinol 22 1985 701 712
197. C. Monder, C.H. Shackleton, H.L. Bradlow, M.I. New, E. Stoner, and F. Iohan The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism J Clin Endocrinol Metab 63 1986 550 557
198. P.M. Stewart, M.A. Wallace, R. Valentino, D. Burt, C.H. Shackleton, and C.R.W. Edwards Mineralocorticoid activity of liquorice: 11-Beta-hydroxysteroid dehydrogenase deficiency comes of age Lancet 1987 821 824
199. P.M. Stewart, J.E.T. Corrie, C.H.L. Shackleton, and C.R.W. Edwards Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle J Clin Invest 82 1988 340 349
200. C.R.W. Edwards, D. Burt, M.A. McIntyre, E.R. De Kloet, P.M. Stewart, and L. Brett Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor Lancet 2 1988 986 989
201. J.W. Funder, P.T. Pearce, R. Smith, and A.I. Smith Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated Science 242 1988 583 585
202. A.S. Brem, K.L. Matheson, T. Conca, and D.J. Morris Effect of carbenoxolone on glucocorticoid metabolism and Na transport in toad bladder Am J Physiol 257 1989 F700 F704
203. R. Castelle, R. Schwarting, C. Miuller, and K. Hierhelzer Immunohistochemical localization of 11-hydroxysteroid dehydrogenase in rat kidney with moncolonal antibody Renal Phys Biochem 12 5-6 1989 320 327
204. Z. Krozowski, S. Stuchberry, P.C. White, C. Monder, and J.W. Funder Characterization of 11β-hydroxysteroid dehydrogenase gene expression: Identification of multiple unique forms of messenger ribonucleic acid in the rat kidney Endocrinology 127 1990 3009 3013
205. A. Naray-Fejes-Toth, C.O. Watlington, and G. Fejes-Toth 11β-Hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone Endocrinology 129 1991 17 21
206. A.S. Brem, and D.J. Morris Interactions between glucocorticoids and mineralocorticoids in the regulation of renal electrolyte transport Mol Cell Endocrinol 97 1993 C1 C5
207. C. Monder The forms and functions of 11β-hydroxysteroid dehydrogenase J Steroid Biochem Mol Biol 45 1993 161 165
208. A.S. Brem, R.B. Bina, J.R. Klinger, T. King, and J.C. Werner Glucocorticoid metabolism in the newborn rat heart Proc Soc Expt Biol Med 209 1995 146 151
209. A.S. Brem, R.B. Bina, T. King, and D.J. Morris Bidirectional activity of 11β-hydroxysteroid dehydrogenase in vascular smooth muscle cells Steroids 60 1995 406 410
210. A. Naray-Fejes-Toth, and G. Fejes-Toth Subcellular localization of the type 2 11beta-hydroxysteroid dehydrogenase. A green fluorescent protein study J Biol Chem 271 1996 15436 15442
211. A. Odermatt, P. Arnold, and F.J. Frey The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2 J Biol Chem 276 2001 28484 28492
212. D.J. Morris, A.S. Brem, R. Ge, P.H. Jellinck, R.R. Sakai, and M.P. Hardy The functional roles of 11beta-HSD1: vascular tissue, testis and brain Mol Cell Endocrinol 203 2003 1 12
213. E.P. Gomez-Sanchez, and C.E. Gomez-Sanchez First there was one, then two.why more 11beta-hydroxysteroid dehydrogenases? Endocrinology 138 1997 5087 5088
214. +-dependent 11β-hydroxysteroid dehydrogenase (11-HSD3) Steroids 62 1997 444 450
215. +-dependent 11β-hydroxysteroid dehydrogenase in the human heart J Mol Cell Cardiol 28 1996 781 787
216. S. Ohno, S. Nakagawara, Y. Honda, and S. Nakajin Evidence for expression of 11beta-hydroxysteroid dehydrogenase type3 (HSD11B3/HSD11B1L) in neonatal pig testis Mol Cell Biochem 381 2013 145 156
217. P.M. Stewart, B.A. Murry, and J.I. Mason Human kidney 11β-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide dependent enzyme and differs from the cloned type I isoform J Clin Endocrinol Metab 79 1994 480 484
218. A.K. Agarwal, F.M. Rogerson, T. Mune, and P.C. White Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11 beta-hydroxysteroid dehydrogenase Genomics 29 1995 195 199
219. J.R. Seckl, and B.R. Walker Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action Endocrinology 142 2001 1371 1376
220. K. Chapman, M. Holmes, and J. Seckl 11beta-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action Physiol Rev 93 2013 1139 1206
221. I.J. Bujalska, E.A. Walker, M. Hewison, and P.M. Stewart A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells J Clin Endocrinol Metab 87 2002 1205 1210
222. I.J. Bujalska, N. Draper, Z. Michailidou, J.W. Tomlinson, P.C. White, and K.E. Chapman Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1 J Mol Endocrinol 34 2005 675 684
223. A.G. Atanasov, L.G. Nashev, R.A. Schweizer, C. Frick, and A. Odermatt Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase FEBS Lett 571 2004 129 133
224. M.Y. Zhou, E.P. Gomez-Sanchez, D.L. Cox, D. Cosby, and C.E. Gomez-Sanchez Cloning, expression and tissue distribution of the rat NAD+-dependent 11β-hydroxysteroid dehydrogenase Endocrinology 136 1995 3729 3734
225. A. Naray-Fejes-Toth, and G. Fejes-Toth Extranuclear localization of endogenous 11beta-hydroxysteroid dehydrogenase-2 in aldosterone target cells Endocrinology 139 1998 2955 2959
226. J.W. Funder Mineralocorticoid receptor activation and oxidative stress Hypertension 50 2007 840 841
227. A.S. Brem, K.L. Matheson, S. Latif, and D.J. Morris Activity of 11 beta-hydroxysteroid dehydrogenase in toad bladder: effects of 11-dehydrocorticosterone Am J Physiol 264 1993 F854 F858
228. A.S. Brem, K.L. Matheson, J.L. Barnes, and D.J. Morris 11-Dehydrocorticosterone, a glucocorticoid metabolite, inhibits aldosterone action in toad bladder Am J Physiol 261 1991 F873 F879
229. E.P. Gomez-Sanchez, V. Ganjam, Y.J. Chen, Y. Liu, S.A. Clark, and C.E. Gomez-Sanchez The 11beta hydroxysteroid dehydrogenase 2 exists as an inactive dimer Steroids 66 2001 845 848
230. E.P. Gomez-Sanchez, V. Ganjam, Y.J. Chen, Y. Liu, M.Y. Zhou, and C. Toroslu Regulation of 11 beta-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol Am J Physiol Endocrinol Metab 285 2003 E272 E279
231. J.R. Seckl, and K.E. Chapman Medical and physiological aspects of the 11beta-hydroxysteroid dehydrogenase system Eur J Biochem 249 1997 361 364
232. R. Diaz, R.W. Brown, and J.R. Seckl Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions J Neurosci 18 1998 2570 2580
233. L.A. Welberg, J.R. Seckl, and M.C. Holmes Inhibition of 11beta-hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behaviour in the offspring Eur J Neurosci 12 2000 1047 1054
234. E.C. Cottrell, M.C. Holmes, D.E. Livingstone, C.J. Kenyon, and J.R. Seckl Reconciling the nutritional and glucocorticoid hypotheses of fetal programming FASEB J 26 2012 1866 1874
235. H.J. Speirs, J.R. Seckl, and R.W. Brown Ontogeny of glucocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development J Endocrinol 181 2004 105 116
236. G. Hirasawa, J. Takeyama, H. Sasano, K. Fukushima, T. Suzuki, and Y. Muramatu 11Beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human placenta J Clin Endocrinol Metab 85 2000 1306 1309
237. G. Hirasawa, H. Sasano, T. Suzuki, J. Takeyama, Y. Muramatu, and K. Fukushima 11Beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor in human fetal development J Clin Endocrinol Metab 84 1999 1453 1458
238. J. Condon, C. Gosden, D. Gardener, P. Nickson, M. Hewison, and A.J. Howie Expression of type 2 11beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life J Clin Endocrinol Metab 83 1998 4490 4497
239. J. Condon, M.L. Ricketts, C.B. Whorwood, and P.M. Stewart Ontogeny and sexual dimorphic expression of mouse type 2 11beta-hydroxysteroid dehydrogenase Mol Cell Endocrinol 127 1997 121 128
240. P.J. Burton, R.E. Smith, Z.S. Krozowski, and B.J. Waddell Zonal distribution of 11 beta-hydroxysteroid dehydrogenase types 1 and 2 messenger ribonucleic acid expression in the rat placenta and decidua during late pregnancy Biol Reprod 55 1996 1023 1028
241. T.Y. Zhang, B. Labonte, X.L. Wen, G. Turecki, and M.J. Meaney Epigenetic mechanisms for the early environmental regulation of hippocampal glucocorticoid receptor gene expression in rodents and humans Neuropsychopharmacology 38 2013 111 123
242. R.G. Hunter Epigenetic effects of stress and corticosteroids in the brain Front Cell Neurosci 6 2012 18
243. A. Harris, and J. Seckl Glucocorticoids, prenatal stress and the programming of disease Horm Behav 59 2011 279 289
244. C.S. Wyrwoll, M.C. Holmes, and J.R. Seckl 11beta-Hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress Front Neuroendocrinol 2010
245. R.M. Reynolds, B.R. Walker, D.I. Phillips, E.M. Dennison, R. Fraser, and S.M. Mackenzie Programming of hypertension: associations of plasma aldosterone in adult men and women with birthweight, cortisol, and blood pressure Hypertension 53 2009 932 936
246. Z. Krozowski, K.X. Li, K. Koyama, R.E. Smith, V.R. Obeyesekere, and A. Stein-Oakley The type I and type II 11beta-hydroxysteroid dehydrogenase enzymes [Review] [71 refs] J Steroid Biochem Mol Biol 69 1999 391 401
247. R. Gong, D.J. Morris, and A.S. Brem Human renal 11beta-hydroxysteroid dehydrogenase 1 functions and co-localizes with COX-2 Life Sci 82 2008 631 637
248. P.M. Driver, M.D. Kilby, I. Bujalska, E.A. Walker, M. Hewison, and P.M. Stewart Expression of 11 beta-hydroxysteroid dehydrogenase isozymes and corticosteroid hormone receptors in primary cultures of human trophoblast and placental bed biopsies Mol Hum Reprod 7 2001 357 363
249. P.W. Hadoke, T. Kipari, J.R. Seckl, and K.E. Chapman Modulation of 11beta-hydroxysteroid dehydrogenase as a strategy to reduce vascular inflammation Curr Atherosclerosis Rep 15 2013 320
250. T.Q. Cai, B. Wong, S.S. Mundt, R. Thieringer, S.D. Wright, and A. Hermanowski-Vosatka Induction of 11beta-hydroxysteroid dehydrogenase type 1 but not -2 in human aortic smooth muscle cells by inflammatory stimuli J Steroid Biochem Mol Biol 77 2001 117 122
251. T.J. Acosta, M. Tetsuka, M. Matsui, T. Shimizu, B. Berisha, and D. Schams In vivo evidence that local cortisol production increases in the preovulatory follicle of the cow J Reprod Dev 51 2005 483 489
252. M. Tetsuka, S. Yamamoto, N. Hayashida, K.G. Hayashi, M. Hayashi, and T.J. Acosta Expression of 11beta-hydroxysteroid dehydrogenases in bovine follicle and corpus luteum J Endocrinol 177 2003 445 452
253. M. Tetsuka, M. Milne, G.E. Simpson, and S.G. Hillier Expression of 11 beta-hydroxysteroid dehydrogenase, glucocorticoid receptor, and mineralocorticoid receptor genes in rat ovary Biol Reprod 60 1999 330 335
254. M. Tetsuka, L.C. Haines, M. Milne, G.E. Simpson, and S.G. Hillier Regulation of 11beta-hydroxysteroid dehydrogenase type 1 gene expression by LH and interleukin-1beta in cultured rat granulosa cells J Endocrinol 163 1999 417 423
255. R. Alikhani-Koopaei, F. Fouladkou, F.J. Frey, and B.M. Frey Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression J Clin Invest 114 2004 1146 1157
256. T. Kipari, P.W. Hadoke, J. Iqbal, T.Y. Man, E. Miller, and A.E. Coutinho 11beta-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis Faseb J 27 2013 1519 1531
257. A. Tiganescu, A.A. Tahrani, S.A. Morgan, M. Otranto, A. Desmouliere, and L. Abrahams 11beta-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects J Clin Invest 123 2013 3051 3060
258. M.C. Holmes, R.N. Carter, J. Noble, S. Chitnis, A. Dutia, and J.M. Paterson 11beta-hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse hippocampus and parietal cortex and causes memory impairments J Neurosci 30 2010 6916 6920
259. M.C. Holmes, and J.R. Seckl The role of 11beta-hydroxysteroid dehydrogenases in the brain Mol Cell Endocrinol 248 2006 9 14
260. J.R. Seckl, J. Yau, and M. Holmes 11Beta-hydroxysteroid dehydrogenases: a novel control of glucocorticoid action in the brain Endocr Res 28 2002 701 707
261. T.C. Sandeep, J.L. Yau, A.M. MacLullich, J. Noble, I.J. Deary, and B.R. Walker 11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics Proc Natl Acad Sci USA 101 2004 6734 6739
262. B.R. Walker, and J.R. Seckl 11beta-Hydroxysteroid dehydrogenase Type 1 as a novel therapeutic target in metabolic and neurodegenerative disease Expert Opin Ther Targets 7 2003 771 783
263. Z.K. Wan, E. Chenail, H.Q. Li, C. Kendall, Y. Wang, and S. Gingras Synthesis of potent and orally efficacious 11beta-hydroxysteroid dehydrogenase type 1 inhibitor HSD-016 J Org Chem 76 2011 7048 7055
264. G. Hollis, and R. Huber 11beta-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus Diabetes Obes Metab 13 2011 1 6
265. A.G. Atanasov, and A. Odermatt Readjusting the glucocorticoid balance: an opportunity for modulators of 11beta-hydroxysteroid dehydrogenase type 1 activity? Endocr Metab Immune Disord Drug Targets 7 2007 125 140
266. N. Draper, and P.M. Stewart 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action J Endocrinol 186 2005 251 271
267. S. Nair, Y.H. Lee, R.S. Lindsay, B.R. Walker, P.A. Tataranni, and C. Bogardus 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle Diabetologia 47 2004 1088 1095
268. P.U. Feig, S. Shah, A. Hermanowski-Vosatka, D. Plotkin, M.S. Springer, and S. Donahue Effects of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome Diabetes Obes Metab 13 2011 498 504
269. E. Harno, and A. White Will treating diabetes with 11beta-HSD1 inhibitors affect the HPA axis? Trends Endocrinol Metab 21 2010 619 627
270. J.S. Scott, S.S. Bowker, J. Deschoolmeester, S. Gerhardt, D. Hargreaves, and E. Kilgour Discovery of a potent, selective, and orally bioavailable acidic 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitor: discovery of 2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acet ic acid (AZD4017) J Med Chem 55 2012 5951 5964
271. N. Vicker, X. Su, D. Ganeshapillai, A. Smith, A. Purohit, and M.J. Reed Novel non-steroidal inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1 J Steroid Biochem Mol Biol 104 2007 123 129
272. J.K. Youm, K. Park, Y. Uchida, A. Chan, T.M. Mauro, and W.M. Holleran Local blockade of glucocorticoid activation reverses stress- and glucocorticoid-induced delays in cutaneous wound healing. Wound repair and regeneration: official publication of the Wound Healing Society [and] the European Tissue Repair Society 21 2013 715 722
273. X. Ma, Q.Q. Lian, Q. Dong, and R.S. Ge Environmental inhibitors of 11beta-hydroxysteroid dehydrogenase type 2 Toxicology 285 2011 83 89
274. G.W. Souness, and D.J. Morris 11α- and 11β-Hydroxyprogesterone, potent inhibitors of 11β-hydroxysteroid dehydrogenase, possess hypertensinogenic activity in the rat Hypertension 27 1996 421 425
275. W.E.B. Semafuko, M.F. Sheff, C.A. Grimes, S.A. Latif, A. Sadaniantz, and P. Levinson Inhibition of 11β-hydroxysteroid dehydrogenase and 5β-steroid reductase in urine from patients with congestive heart failure Ann Clin Lab Sci 23 1993 456 461
276. D.J. Morris, W.E.B. Semafuko, S.A. Latif, B. Vogel, C.A. Grimes, and M.F. Sheff Detection of glycyrrhetinic acid-like factors (GALFs) in human urine Hypertension 20 1992 356 360
277. B.R. Walker, I. Aggarwal, P.M. Stewart, P.L. Padfield, and C.R. Edwards Endogenous inhibitors of 11 beta-hydroxysteroid dehydrogenase in hypertension J Clin Endocrinol Metab 80 1995 529 533
278. B.R. Walker, J.C. Campbell, R. Fraser, P.M. Stewart, and C.R.W. Edwards Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome Clin Endocrinol 37 1992 483 492
279. E.P. Gomez-Sanchez, and C.E. Gomez-Sanchez Central Hypertensinogenic effects of glycyrrhizic acid and carbenoxolone Am J Physiol 263 1992 E1125 E1130
280. E.P. Gomez-Sanchez, and C.E. Gomez-Sanchez Maternal hypertension and progeny blood pressure: role of aldosterone and 11β-HSD Hypertension 33 1999 1369 1373
281. Z.H. Zhang, Y.M. Kang, Y. Yu, S.G. Wei, T.J. Schmidt, and A.K. Johnson 11beta-hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation Hypertension 48 2006 127 133
282. M.-P. Moisan, J.R. Seckl, and C.R.W. Edwards 11β-Hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex Endocrinology 127 1990 1450 1455
283. J.R. Seckl, R.W. Brown, V. Rajan, S.C. Low, and C.R.W. Edwards 11β-Hydroxysteroid dehydrogenase and corticosteroid actions in the brain J Endocrinol 137 1993 S9
284. R.W. Brown, R. Diaz, A.C. Robson, Y.V. Kotelevtsev, J.J. Mullins, and M.H.S. Kaufman The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development Endocrinology 137 1996 794 797
285. B.L. Roland, K.X. Li, and J.W. Funder Hybridization histochemical localization of 11 beta-hydroxysteroid dehydrogenase type 2 in rat brain Endocrinology 136 1995 4697 4700
286. J.C. Geerling, M. Kawata, and A.D. Loewy Aldosterone-sensitive neurons in the rat central nervous system J Comp Neurol 494 2006 515 527
287. J.C. Geerling, and A.D. Loewy Aldosterone in the brain Am J Physiol Renal Physiol 297 2009 F559 F576
288. J.C. Geerling, and A.D. Loewy Sodium deprivation and salt intake activate separate neuronal subpopulations in the nucleus of the solitary tract and the parabrachial complex J Comp Neurol 504 2007 379 403
289. I. Bujalska, M. Shimojo, A. Howie, and P.M. Stewart Human 11 beta-hydroxysteroid dehydrogenase: studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue Steroids 62 1997 77 82
290. E.P. Gomez-Sanchez, D.G. Romero, A.F. de Rodriguez, M.P. Warden, Z. Krozowski, and C.E. Gomez-Sanchez Hexose-6-phosphate dehydrogenase and 11{beta}-hydroxysteroid dehydrogenase-1 tissue distribution in the rat Endocrinology 149 2008 525 533
291. F.L. Groeneweg, H. Karst, E.R. de Kloet, and M. Joels Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling Mol Cell Endocrinol 2011
292. N. Pasricha, M. Joels, and H. Karst Rapid effects of corticosterone in the mouse dentate gyrus via a nongenomic pathway J Neuroendocrinol 23 2011 143 147
293. M. Zhou, M. Kindt, M. Joels, and H.J. Krugers Blocking mineralocorticoid receptors prior to retrieval reduces contextual fear memory in mice PLoS One 6 2011 e26220
294. I.C. Weaver, N. Cervoni, F.A. Champagne, A.C. D'Alessio, S. Sharma, and J.R. Seckl Epigenetic programming by maternal behavior Nat Neurosci 7 2004 847 854
295. H. Karst, S. Berger, M. Turiault, F. Tronche, G. Schutz, and M. Joels Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone Proc Natl Acad Sci USA 102 2005 19204 19207
296. C. Kellendonk, P. Gass, O. Kretz, G. Schutz, and F. Tronche Corticosteroid receptors in the brain: gene targeting studies Brain Res Bull 57 2002 73 83
297. X.R. Qi, W. Kamphuis, S. Wang, Q. Wang, P.J. Lucassen, and J.N. Zhou Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients Psychoneuroendocrinology 38 2012 863 870
298. M. Lai, K. Horsburgh, S.E. Bae, R.N. Carter, D.J. Stenvers, and J.H. Fowler Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia Eur J Neurosci 25 2007 1832 1842
299. D. Ferguson, and R. Sapolsky Mineralocorticoid receptor overexpression differentially modulates specific phases of spatial and nonspatial memory J Neurosci 27 2007 8046 8052
300. R. Mitra, D. Ferguson, and R.M. Sapolsky Mineralocorticoid receptor overexpression in basolateral amygdala reduces corticosterone secretion and anxiety Biol Psychiatry 66 2009 686 690
301. N.A. Datson, J.M. van den Oever, O.B. Korobko, A.M. Magarinos, E.R. de Kloet, and B.S. McEwen Previous history of chronic stress changes the transcriptional response to glucocorticoid challenge in the dentate gyrus region of the male rat hippocampus Endocrinology 154 2013 3261 3272
302. E.P. Gomez-Sanchez, M.T. Venkataraman, D. Thwaites, and C. Fort ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension Am J Physiol 258 1990 E649 E653
303. D.T.W.M. van den Berg, E.R. De Kloet, H.H. van Dijken, and W. de Jong Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure Endocrinology 126 1990 118 124
304. S. Pyner, and J.H. Coote Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord Neuroscience 100 2000 549 556
305. C. Otte, K. Hinkelmann, S. Moritz, A. Yassouridis, H. Jahn, and K. Wiedemann Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study J Psychiatr Res 44 2010 339 346
306. A.J. Grippo, J.A. Moffitt, A. Sgoifo, A.J. Jepson, S.L. Bates, and D.L. Chandler The integration of depressive behaviors and cardiac dysfunction during an operational measure of depression: investigating the role of negative social experiences in an animal model Psychosom Med 74 2012 612 619
307. A.J. Grippo, and A.K. Johnson Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models Stress 12 2009 1 21
308. E. Emanuele, D. Geroldi, P. Minoretti, E. Coen, and P. Politi Increased plasma aldosterone in patients with clinical depression Arch Med Res 36 2005 544 548
309. H. Selye, and H. Stone Pathogenesis of the cardiovascular and renal changes which usually accompany malignant hypertension J Urol 56 1946 399 419
310. E.R. de Kloet, R.H. Derijk, and O.C. Meijer Therapy Insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression? Nat Clin Pract Endocrinol Metab 3 2007 168 179